﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/alembic-pharmaceuticals-gets-usfda-nod-for-generic-parkinsons-disease-treatment-tablets-19054</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/hologics-aptima-hpv-test-bags-fda-nod-for-primary-cervical-cancer-screening-19064</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/apotex-scores-exclusive-canadian-rights-to-testosterone-therapy-nebido-19063</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/aicuris-pritelivir-delivers-phase-3-win-in-hard-to-treat-herpes-patients-19062</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/1bn-london-cancer-hub-expansion-wins-planning-approval-19061</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/pfizers-hympavzi-bags-fda-priority-review-targeting-younger-hard-to-treat-hemophilia-patients-19060</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/novo-nordisk-threatens-legal-action-over-hims-hers-knockoff-semaglutide-pill-19059</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-receives-usfda-odd-for-desidustat-for-the-treatment-of-sickle-cell-disease-19058</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/gsks-nucala-receives-european-commission-approval-to-treat-chronic-obstructive-pulmonary-disease-19057</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fujifilm-india-unveils-four-new-imaging-healthcare-it-solutions-at-iria-2026-19056</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/bayers-asundexian-demonstrated-26-reduction-in-stroke-after-a-non-cardioembolic-ischemic-stroke-19055</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fitch-upgrades-biocon-biologics-outlook-to-positive-affirms-bb-rating-19065</loc><lastmod>2026-02-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>